| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chromosomes, Human, Y | 14 | 2020 | 162 | 2.760 |
Why?
|
| Lebanon | 40 | 2024 | 245 | 2.690 |
Why?
|
| Genetics, Population | 22 | 2024 | 929 | 2.150 |
Why?
|
| Haplotypes | 24 | 2020 | 2764 | 2.090 |
Why?
|
| Coronary Artery Disease | 20 | 2024 | 6659 | 1.460 |
Why?
|
| DNA, Mitochondrial | 10 | 2018 | 858 | 1.450 |
Why?
|
| Polymorphism, Single Nucleotide | 33 | 2024 | 15790 | 1.420 |
Why?
|
| Coronary Stenosis | 4 | 2023 | 820 | 1.320 |
Why?
|
| Emigration and Immigration | 7 | 2018 | 395 | 1.270 |
Why?
|
| Cholesterol, HDL | 7 | 2024 | 1817 | 1.140 |
Why?
|
| Genetic Predisposition to Disease | 20 | 2024 | 17790 | 1.080 |
Why?
|
| Apolipoprotein C-I | 1 | 2024 | 13 | 0.980 |
Why?
|
| Population | 3 | 2020 | 140 | 0.940 |
Why?
|
| Gene Flow | 7 | 2019 | 78 | 0.880 |
Why?
|
| Globins | 4 | 2005 | 403 | 0.840 |
Why?
|
| Diabetes Mellitus, Type 2 | 12 | 2024 | 12289 | 0.840 |
Why?
|
| Refugees | 2 | 2023 | 598 | 0.810 |
Why?
|
| Plasma | 3 | 2020 | 584 | 0.780 |
Why?
|
| Genome-Wide Association Study | 13 | 2024 | 12628 | 0.760 |
Why?
|
| Genome, Mitochondrial | 2 | 2018 | 66 | 0.740 |
Why?
|
| Genetic Variation | 19 | 2019 | 6552 | 0.740 |
Why?
|
| History, Ancient | 11 | 2019 | 211 | 0.720 |
Why?
|
| Transcription Factor 7-Like 2 Protein | 2 | 2023 | 152 | 0.690 |
Why?
|
| Urine | 1 | 2020 | 363 | 0.650 |
Why?
|
| Sphingomyelins | 1 | 2019 | 103 | 0.630 |
Why?
|
| beta-Thalassemia | 4 | 2005 | 235 | 0.620 |
Why?
|
| Diabetes Mellitus, Type 1 | 10 | 2013 | 3454 | 0.600 |
Why?
|
| Population Dynamics | 5 | 2018 | 306 | 0.530 |
Why?
|
| Protein Kinase C-alpha | 1 | 2016 | 113 | 0.530 |
Why?
|
| Women | 1 | 2018 | 225 | 0.520 |
Why?
|
| Consanguinity | 6 | 2013 | 456 | 0.500 |
Why?
|
| Phylogeny | 9 | 2018 | 2775 | 0.500 |
Why?
|
| Metabolomics | 6 | 2020 | 1628 | 0.490 |
Why?
|
| Alleles | 9 | 2024 | 6900 | 0.470 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2014 | 112 | 0.460 |
Why?
|
| Demography | 1 | 2018 | 1650 | 0.420 |
Why?
|
| Genome, Human | 11 | 2019 | 4418 | 0.410 |
Why?
|
| Phylogeography | 6 | 2019 | 72 | 0.400 |
Why?
|
| Respiratory Sounds | 1 | 2016 | 697 | 0.400 |
Why?
|
| Syria | 4 | 2023 | 81 | 0.400 |
Why?
|
| Genotype | 16 | 2024 | 12957 | 0.360 |
Why?
|
| Aortic Valve | 1 | 2020 | 1996 | 0.360 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2016 | 4356 | 0.350 |
Why?
|
| Evolution, Molecular | 6 | 2020 | 1885 | 0.350 |
Why?
|
| Peptidyl-Dipeptidase A | 2 | 2010 | 361 | 0.350 |
Why?
|
| Polymorphism, Genetic | 7 | 2021 | 4286 | 0.340 |
Why?
|
| Cholesterol | 1 | 2019 | 2924 | 0.340 |
Why?
|
| Risk Factors | 31 | 2024 | 74333 | 0.340 |
Why?
|
| Humans | 120 | 2024 | 760613 | 0.330 |
Why?
|
| Acculturation | 1 | 2010 | 177 | 0.330 |
Why?
|
| Lipoprotein(a) | 2 | 2023 | 499 | 0.330 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 2 | 2020 | 352 | 0.320 |
Why?
|
| Gene Frequency | 11 | 2017 | 3613 | 0.320 |
Why?
|
| Male | 69 | 2024 | 359718 | 0.320 |
Why?
|
| Ectodysplasins | 1 | 2008 | 11 | 0.320 |
Why?
|
| Middle East | 7 | 2016 | 230 | 0.320 |
Why?
|
| Drug Resistance, Viral | 1 | 2014 | 859 | 0.320 |
Why?
|
| Anemia, Sickle Cell | 2 | 2010 | 1056 | 0.320 |
Why?
|
| RNA, Viral | 4 | 2014 | 2838 | 0.320 |
Why?
|
| Communicable Diseases | 1 | 2016 | 878 | 0.310 |
Why?
|
| Aortic Valve Stenosis | 1 | 2020 | 2065 | 0.300 |
Why?
|
| Polymerase Chain Reaction | 7 | 2007 | 6065 | 0.300 |
Why?
|
| Constriction, Pathologic | 4 | 2023 | 1098 | 0.290 |
Why?
|
| Ectodermal Dysplasia | 1 | 2008 | 106 | 0.290 |
Why?
|
| Hypertension | 4 | 2024 | 8595 | 0.290 |
Why?
|
| Genetic Association Studies | 3 | 2017 | 2716 | 0.280 |
Why?
|
| Archaeology | 2 | 2018 | 36 | 0.270 |
Why?
|
| Pedigree | 4 | 2020 | 4578 | 0.270 |
Why?
|
| Case-Control Studies | 9 | 2024 | 22052 | 0.260 |
Why?
|
| Genetic Loci | 3 | 2023 | 2618 | 0.260 |
Why?
|
| Greece | 2 | 2024 | 336 | 0.260 |
Why?
|
| Codon | 2 | 2008 | 602 | 0.250 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2023 | 4555 | 0.250 |
Why?
|
| Middle Aged | 35 | 2024 | 220359 | 0.250 |
Why?
|
| Microsatellite Repeats | 5 | 2020 | 786 | 0.250 |
Why?
|
| Proteobacteria | 1 | 2005 | 46 | 0.250 |
Why?
|
| Female | 54 | 2024 | 391246 | 0.250 |
Why?
|
| Turkey | 2 | 2024 | 248 | 0.250 |
Why?
|
| Phenotype | 11 | 2021 | 16548 | 0.240 |
Why?
|
| Gene Pool | 4 | 2019 | 35 | 0.240 |
Why?
|
| Water Microbiology | 1 | 2005 | 113 | 0.230 |
Why?
|
| Microfilament Proteins | 2 | 2024 | 1135 | 0.230 |
Why?
|
| Qb-SNARE Proteins | 1 | 2023 | 34 | 0.230 |
Why?
|
| Anti-Retroviral Agents | 1 | 2014 | 1779 | 0.230 |
Why?
|
| DNA, Ribosomal | 1 | 2005 | 285 | 0.230 |
Why?
|
| Genetic Testing | 4 | 2006 | 3531 | 0.230 |
Why?
|
| Water Supply | 1 | 2005 | 206 | 0.220 |
Why?
|
| Mutation, Missense | 2 | 2014 | 2567 | 0.220 |
Why?
|
| Fetal Hemoglobin | 2 | 2003 | 342 | 0.220 |
Why?
|
| Chromosome Disorders | 1 | 2006 | 499 | 0.220 |
Why?
|
| Seafood | 1 | 2006 | 390 | 0.210 |
Why?
|
| Coronary Angiography | 4 | 2023 | 4563 | 0.210 |
Why?
|
| Africa, Northern | 6 | 2019 | 86 | 0.210 |
Why?
|
| Thalassemia | 1 | 2003 | 270 | 0.200 |
Why?
|
| Hepatocyte Nuclear Factor 6 | 1 | 2021 | 9 | 0.200 |
Why?
|
| China | 6 | 2022 | 2339 | 0.200 |
Why?
|
| Odds Ratio | 6 | 2021 | 9716 | 0.200 |
Why?
|
| Adult | 39 | 2024 | 220007 | 0.190 |
Why?
|
| Antigens, Differentiation | 1 | 2004 | 911 | 0.190 |
Why?
|
| Genetic Heterogeneity | 1 | 2005 | 724 | 0.190 |
Why?
|
| Aged | 26 | 2024 | 169143 | 0.190 |
Why?
|
| Mediterranean Region | 2 | 2018 | 47 | 0.190 |
Why?
|
| Geography | 5 | 2015 | 661 | 0.190 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2021 | 114 | 0.180 |
Why?
|
| Mutation | 9 | 2013 | 29957 | 0.180 |
Why?
|
| Nicotine | 1 | 2005 | 677 | 0.180 |
Why?
|
| Fruit | 1 | 2006 | 1160 | 0.180 |
Why?
|
| Africa | 5 | 2019 | 706 | 0.180 |
Why?
|
| Spain | 2 | 2019 | 488 | 0.180 |
Why?
|
| Hepacivirus | 1 | 2007 | 1334 | 0.180 |
Why?
|
| Cresols | 1 | 2020 | 26 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 4 | 2014 | 5782 | 0.180 |
Why?
|
| Vascular System Injuries | 1 | 2023 | 247 | 0.180 |
Why?
|
| DNA, Bacterial | 1 | 2005 | 1456 | 0.170 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 2505 | 0.170 |
Why?
|
| Coronary Restenosis | 1 | 2023 | 426 | 0.170 |
Why?
|
| Nepovirus | 2 | 1996 | 2 | 0.170 |
Why?
|
| Rural Population | 4 | 2022 | 2268 | 0.170 |
Why?
|
| Asthma | 2 | 2016 | 6172 | 0.170 |
Why?
|
| Europe | 10 | 2017 | 3441 | 0.170 |
Why?
|
| Population Density | 3 | 2019 | 192 | 0.160 |
Why?
|
| Cultural Characteristics | 1 | 2020 | 253 | 0.160 |
Why?
|
| Genetic Linkage | 5 | 2017 | 2381 | 0.160 |
Why?
|
| Smoking | 3 | 2017 | 9073 | 0.160 |
Why?
|
| Tumor Virus Infections | 1 | 2002 | 438 | 0.160 |
Why?
|
| Blood Glucose | 3 | 2020 | 6379 | 0.160 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 5325 | 0.160 |
Why?
|
| Bible | 1 | 2018 | 5 | 0.160 |
Why?
|
| Urinalysis | 1 | 2020 | 368 | 0.160 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 3 | 2012 | 275 | 0.150 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2002 | 384 | 0.150 |
Why?
|
| Age of Onset | 5 | 2013 | 3302 | 0.150 |
Why?
|
| Italy | 2 | 2018 | 841 | 0.150 |
Why?
|
| Asia | 6 | 2017 | 620 | 0.150 |
Why?
|
| Influenza in Birds | 1 | 2018 | 76 | 0.150 |
Why?
|
| Hepatitis C | 1 | 2007 | 1579 | 0.140 |
Why?
|
| Leptin | 2 | 2002 | 1590 | 0.140 |
Why?
|
| Exons | 3 | 2008 | 2389 | 0.140 |
Why?
|
| Adolescent | 15 | 2019 | 87809 | 0.140 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2018 | 113 | 0.140 |
Why?
|
| Chromosomes, Human, X | 2 | 2016 | 321 | 0.140 |
Why?
|
| Prenatal Diagnosis | 1 | 2004 | 1264 | 0.140 |
Why?
|
| Recombination, Genetic | 2 | 2011 | 1526 | 0.140 |
Why?
|
| Periodontitis | 1 | 2021 | 560 | 0.140 |
Why?
|
| Tunisia | 1 | 2016 | 36 | 0.140 |
Why?
|
| Medical Records | 1 | 2002 | 1407 | 0.140 |
Why?
|
| Influenza, Human | 2 | 2018 | 1528 | 0.140 |
Why?
|
| Osteoporosis | 2 | 2022 | 1601 | 0.140 |
Why?
|
| Cyprus | 1 | 2016 | 96 | 0.140 |
Why?
|
| HIV-1 | 1 | 2014 | 6849 | 0.140 |
Why?
|
| Factor V | 2 | 2010 | 168 | 0.130 |
Why?
|
| Thromboembolism | 1 | 2003 | 1016 | 0.130 |
Why?
|
| Tooth | 1 | 2018 | 208 | 0.130 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 11890 | 0.130 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2015 | 69 | 0.130 |
Why?
|
| Sentinel Surveillance | 1 | 2018 | 293 | 0.130 |
Why?
|
| Viral Core Proteins | 1 | 1996 | 161 | 0.130 |
Why?
|
| Africa South of the Sahara | 3 | 2019 | 742 | 0.130 |
Why?
|
| HLA-DQ Antigens | 3 | 2009 | 211 | 0.130 |
Why?
|
| Lipoproteins, LDL | 1 | 2019 | 641 | 0.130 |
Why?
|
| Chickens | 1 | 2018 | 860 | 0.130 |
Why?
|
| Bone Density | 2 | 2022 | 3534 | 0.130 |
Why?
|
| Papillomaviridae | 1 | 2002 | 1117 | 0.130 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2021 | 1112 | 0.130 |
Why?
|
| Prevalence | 7 | 2014 | 15686 | 0.130 |
Why?
|
| Dyslipidemias | 1 | 2023 | 895 | 0.120 |
Why?
|
| tRNA Methyltransferases | 1 | 2014 | 52 | 0.120 |
Why?
|
| Pancreas | 1 | 2021 | 1677 | 0.120 |
Why?
|
| Arabs | 1 | 2017 | 187 | 0.120 |
Why?
|
| Polymorphism, Restriction Fragment Length | 3 | 2005 | 761 | 0.120 |
Why?
|
| Cholesterol, LDL | 3 | 2019 | 2420 | 0.120 |
Why?
|
| Lipoproteins, HDL | 1 | 2019 | 667 | 0.120 |
Why?
|
| Reverse Transcription | 1 | 2014 | 47 | 0.120 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 2 | 2007 | 164 | 0.110 |
Why?
|
| HIV Protease | 1 | 2014 | 97 | 0.110 |
Why?
|
| Amyloidosis, Familial | 1 | 2013 | 16 | 0.110 |
Why?
|
| Culture | 1 | 2018 | 622 | 0.110 |
Why?
|
| Diabetes Mellitus | 2 | 2023 | 5890 | 0.110 |
Why?
|
| Bioartificial Organs | 1 | 2013 | 47 | 0.110 |
Why?
|
| Alstrom Syndrome | 1 | 2013 | 11 | 0.110 |
Why?
|
| Cultural Evolution | 1 | 2013 | 9 | 0.110 |
Why?
|
| Cluster Analysis | 4 | 2016 | 2698 | 0.110 |
Why?
|
| HIV Reverse Transcriptase | 1 | 2014 | 212 | 0.110 |
Why?
|
| Hyperglycemia | 1 | 2021 | 1380 | 0.110 |
Why?
|
| Base Sequence | 7 | 2017 | 12444 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 4 | 2014 | 4716 | 0.100 |
Why?
|
| Corneal Dystrophies, Hereditary | 1 | 2013 | 63 | 0.100 |
Why?
|
| Regression Analysis | 2 | 2020 | 6359 | 0.100 |
Why?
|
| Chi-Square Distribution | 3 | 2010 | 3465 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 368 | 0.100 |
Why?
|
| Heart Valve Prosthesis | 1 | 2020 | 1495 | 0.100 |
Why?
|
| Principal Component Analysis | 4 | 2017 | 939 | 0.100 |
Why?
|
| Mass Spectrometry | 1 | 2019 | 2192 | 0.100 |
Why?
|
| Young Adult | 10 | 2021 | 58748 | 0.100 |
Why?
|
| Hyperhomocysteinemia | 1 | 2012 | 118 | 0.100 |
Why?
|
| Membrane Proteins | 1 | 2008 | 7850 | 0.100 |
Why?
|
| Caffeine | 1 | 2015 | 702 | 0.090 |
Why?
|
| Genetic Markers | 2 | 2008 | 2609 | 0.090 |
Why?
|
| Genes, Transgenic, Suicide | 1 | 2010 | 34 | 0.090 |
Why?
|
| Interferon-alpha | 2 | 2007 | 919 | 0.090 |
Why?
|
| Biological Evolution | 2 | 2015 | 1074 | 0.090 |
Why?
|
| Fertility Agents, Female | 1 | 2010 | 101 | 0.090 |
Why?
|
| Respiratory Tract Infections | 1 | 2018 | 1007 | 0.090 |
Why?
|
| Inflammation | 2 | 2023 | 10755 | 0.090 |
Why?
|
| Mortality | 1 | 2021 | 2916 | 0.090 |
Why?
|
| Milk | 2 | 2003 | 443 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2002 | 1607 | 0.090 |
Why?
|
| Population Groups | 1 | 2010 | 211 | 0.080 |
Why?
|
| Cost of Illness | 2 | 2018 | 1940 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 15840 | 0.080 |
Why?
|
| Infection Control | 1 | 2016 | 983 | 0.080 |
Why?
|
| Chromosome Mapping | 2 | 2015 | 4626 | 0.080 |
Why?
|
| Tandem Repeat Sequences | 2 | 2009 | 181 | 0.080 |
Why?
|
| Mediterranean Sea | 1 | 2008 | 13 | 0.080 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2010 | 278 | 0.080 |
Why?
|
| Prosthesis Implantation | 1 | 2013 | 594 | 0.080 |
Why?
|
| Child | 11 | 2018 | 79799 | 0.080 |
Why?
|
| Wolfram Syndrome | 1 | 2008 | 15 | 0.080 |
Why?
|
| Stroke | 2 | 2022 | 9952 | 0.080 |
Why?
|
| Child, Preschool | 8 | 2018 | 42056 | 0.080 |
Why?
|
| Homocysteine | 1 | 2012 | 640 | 0.080 |
Why?
|
| Body Height | 1 | 2015 | 1570 | 0.080 |
Why?
|
| Disease Outbreaks | 1 | 2018 | 1758 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2013 | 1697 | 0.080 |
Why?
|
| Cohort Studies | 6 | 2022 | 41337 | 0.080 |
Why?
|
| Streptococcus agalactiae | 1 | 2010 | 337 | 0.080 |
Why?
|
| Diet | 1 | 2006 | 8010 | 0.080 |
Why?
|
| Echocardiography | 1 | 2020 | 4981 | 0.080 |
Why?
|
| Health Services Needs and Demand | 1 | 2016 | 1399 | 0.070 |
Why?
|
| Drug Costs | 1 | 2016 | 1185 | 0.070 |
Why?
|
| Behcet Syndrome | 1 | 2008 | 86 | 0.070 |
Why?
|
| Cross-Sectional Studies | 7 | 2020 | 25941 | 0.070 |
Why?
|
| Brucellosis | 1 | 2007 | 21 | 0.070 |
Why?
|
| HIV Infections | 1 | 2014 | 17165 | 0.070 |
Why?
|
| Histocytological Preparation Techniques | 1 | 2007 | 33 | 0.070 |
Why?
|
| Biotinidase Deficiency | 1 | 2006 | 3 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 1996 | 1894 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 12159 | 0.070 |
Why?
|
| Isotretinoin | 1 | 2008 | 131 | 0.070 |
Why?
|
| HTLV-I Infections | 1 | 2007 | 103 | 0.070 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 4742 | 0.070 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 2007 | 142 | 0.070 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2006 | 62 | 0.070 |
Why?
|
| Microbiological Techniques | 1 | 2007 | 98 | 0.070 |
Why?
|
| Heterozygote | 3 | 2016 | 2798 | 0.070 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2010 | 497 | 0.060 |
Why?
|
| Antigens, CD | 2 | 2008 | 4000 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2006 | 228 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2006 | 194 | 0.060 |
Why?
|
| Language | 2 | 2015 | 1533 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2006 | 246 | 0.060 |
Why?
|
| Albinism, Oculocutaneous | 1 | 2005 | 19 | 0.060 |
Why?
|
| Logistic Models | 4 | 2016 | 13312 | 0.060 |
Why?
|
| Streptococcal Infections | 1 | 2010 | 617 | 0.060 |
Why?
|
| Monophenol Monooxygenase | 1 | 2005 | 74 | 0.060 |
Why?
|
| Proviruses | 1 | 2007 | 313 | 0.060 |
Why?
|
| Cotinine | 1 | 2005 | 203 | 0.060 |
Why?
|
| Risk Assessment | 4 | 2016 | 24102 | 0.060 |
Why?
|
| Zidovudine | 1 | 2007 | 624 | 0.060 |
Why?
|
| Algorithms | 3 | 2019 | 13982 | 0.060 |
Why?
|
| Quantitative Trait Loci | 1 | 2012 | 2101 | 0.060 |
Why?
|
| Dermatologic Agents | 1 | 2008 | 307 | 0.060 |
Why?
|
| Infant | 6 | 2021 | 36053 | 0.060 |
Why?
|
| Insurance Coverage | 1 | 2016 | 1939 | 0.060 |
Why?
|
| Iran | 3 | 2015 | 738 | 0.060 |
Why?
|
| Ethiopia | 2 | 2016 | 462 | 0.060 |
Why?
|
| NF-kappa B | 2 | 2010 | 2486 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2005 | 1055 | 0.060 |
Why?
|
| Oligonucleotide Probes | 1 | 2004 | 418 | 0.060 |
Why?
|
| Depression | 1 | 2023 | 8045 | 0.060 |
Why?
|
| Hemoglobin A2 | 1 | 2003 | 6 | 0.060 |
Why?
|
| Blood Protein Electrophoresis | 1 | 2003 | 71 | 0.050 |
Why?
|
| Family Health | 2 | 2010 | 1257 | 0.050 |
Why?
|
| Health Expenditures | 1 | 2016 | 2362 | 0.050 |
Why?
|
| Hemoglobin A | 1 | 2003 | 84 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2023 | 173 | 0.050 |
Why?
|
| Health Personnel | 1 | 2016 | 3310 | 0.050 |
Why?
|
| Spasms, Infantile | 1 | 2006 | 296 | 0.050 |
Why?
|
| Birth Order | 1 | 2003 | 95 | 0.050 |
Why?
|
| alpha-Thalassemia | 1 | 2003 | 52 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 4571 | 0.050 |
Why?
|
| Homozygote | 2 | 2004 | 1788 | 0.050 |
Why?
|
| Arsenicals | 1 | 2003 | 117 | 0.050 |
Why?
|
| Health | 1 | 2005 | 396 | 0.050 |
Why?
|
| Coronary Disease | 1 | 2017 | 5991 | 0.050 |
Why?
|
| Hypereosinophilic Syndrome | 1 | 2003 | 96 | 0.050 |
Why?
|
| Receptors, CCR5 | 1 | 2004 | 488 | 0.050 |
Why?
|
| Syndrome | 1 | 2008 | 3280 | 0.050 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 17624 | 0.050 |
Why?
|
| Linkage Disequilibrium | 2 | 2017 | 1996 | 0.050 |
Why?
|
| Streptozocin | 1 | 2021 | 194 | 0.050 |
Why?
|
| Anthropometry | 1 | 2006 | 1348 | 0.050 |
Why?
|
| Point Mutation | 1 | 2006 | 1594 | 0.050 |
Why?
|
| Oxides | 1 | 2003 | 401 | 0.050 |
Why?
|
| Drinking | 1 | 2002 | 199 | 0.050 |
Why?
|
| Aspartate Aminotransferases | 1 | 2022 | 415 | 0.050 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 58980 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2005 | 1006 | 0.050 |
Why?
|
| Species Specificity | 1 | 2005 | 2418 | 0.050 |
Why?
|
| Antiviral Agents | 2 | 2018 | 3061 | 0.040 |
Why?
|
| Models, Genetic | 3 | 2017 | 3442 | 0.040 |
Why?
|
| Y Chromosome | 1 | 2001 | 205 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2013 | 4426 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 1 | 2003 | 652 | 0.040 |
Why?
|
| Organogenesis | 1 | 2021 | 215 | 0.040 |
Why?
|
| Absorptiometry, Photon | 1 | 2006 | 1736 | 0.040 |
Why?
|
| Gallbladder | 1 | 2021 | 305 | 0.040 |
Why?
|
| Comorbidity | 1 | 2014 | 10553 | 0.040 |
Why?
|
| Autoantibodies | 1 | 2008 | 2119 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2005 | 15760 | 0.040 |
Why?
|
| Multigene Family | 1 | 2003 | 1077 | 0.040 |
Why?
|
| Fossils | 1 | 2019 | 75 | 0.040 |
Why?
|
| Obesity | 2 | 2020 | 12919 | 0.040 |
Why?
|
| Pancreatic Diseases | 1 | 2021 | 343 | 0.040 |
Why?
|
| Animals | 9 | 2023 | 167960 | 0.040 |
Why?
|
| Fabaceae | 2 | 1996 | 103 | 0.040 |
Why?
|
| Fasting | 1 | 2005 | 1603 | 0.040 |
Why?
|
| Nutrition Surveys | 1 | 2006 | 1725 | 0.040 |
Why?
|
| Vaginal Smears | 1 | 2002 | 495 | 0.040 |
Why?
|
| Plants, Medicinal | 2 | 1996 | 166 | 0.040 |
Why?
|
| Body Mass Index | 3 | 2021 | 12914 | 0.040 |
Why?
|
| Premature Birth | 1 | 2010 | 1770 | 0.040 |
Why?
|
| Proteins | 1 | 2013 | 6029 | 0.040 |
Why?
|
| Sex Distribution | 1 | 2003 | 2294 | 0.040 |
Why?
|
| Hospitalization | 1 | 2018 | 10789 | 0.040 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2010 | 2125 | 0.040 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2018 | 83 | 0.040 |
Why?
|
| Oseltamivir | 1 | 2018 | 76 | 0.040 |
Why?
|
| Fetal Growth Retardation | 1 | 2021 | 579 | 0.040 |
Why?
|
| Vitamin B 12 | 1 | 2020 | 522 | 0.040 |
Why?
|
| Triglycerides | 2 | 2015 | 2476 | 0.040 |
Why?
|
| Chad | 1 | 2016 | 8 | 0.040 |
Why?
|
| Reproducibility of Results | 3 | 2017 | 20080 | 0.040 |
Why?
|
| Postmenopause | 1 | 2006 | 2509 | 0.040 |
Why?
|
| Seasons | 1 | 2003 | 1522 | 0.040 |
Why?
|
| Morbidity | 1 | 2022 | 1765 | 0.040 |
Why?
|
| Creatinine | 1 | 2022 | 1904 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2002 | 1368 | 0.030 |
Why?
|
| Pilot Projects | 2 | 2018 | 8556 | 0.030 |
Why?
|
| Congenital Abnormalities | 1 | 2021 | 704 | 0.030 |
Why?
|
| Probability | 1 | 2002 | 2475 | 0.030 |
Why?
|
| Ribonuclease H | 1 | 1996 | 50 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2003 | 1328 | 0.030 |
Why?
|
| Armenia | 1 | 2015 | 15 | 0.030 |
Why?
|
| Databases, Genetic | 2 | 2014 | 1738 | 0.030 |
Why?
|
| Neoplasms | 2 | 2016 | 22075 | 0.030 |
Why?
|
| Age Distribution | 1 | 2002 | 2893 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 3484 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2004 | 4108 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2015 | 89 | 0.030 |
Why?
|
| Aryldialkylphosphatase | 1 | 2015 | 63 | 0.030 |
Why?
|
| Sex Factors | 2 | 2015 | 10546 | 0.030 |
Why?
|
| Nasopharynx | 1 | 2018 | 394 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2002 | 2194 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2003 | 1355 | 0.030 |
Why?
|
| Pluripotent Stem Cells | 1 | 2021 | 792 | 0.030 |
Why?
|
| Rats | 2 | 2021 | 23709 | 0.030 |
Why?
|
| Dyspnea | 1 | 2022 | 1353 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2022 | 80345 | 0.030 |
Why?
|
| Data Interpretation, Statistical | 1 | 2004 | 2696 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1996 | 778 | 0.030 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2018 | 448 | 0.030 |
Why?
|
| Mass Screening | 1 | 2010 | 5422 | 0.030 |
Why?
|
| Leukotrienes | 1 | 2015 | 231 | 0.030 |
Why?
|
| Diabetic Nephropathies | 1 | 2001 | 988 | 0.030 |
Why?
|
| Diabetes Insipidus, Neurogenic | 1 | 2013 | 20 | 0.030 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2016 | 412 | 0.030 |
Why?
|
| Multifactorial Inheritance | 1 | 2021 | 1365 | 0.030 |
Why?
|
| Ketosis | 1 | 2013 | 46 | 0.030 |
Why?
|
| Agriculture | 1 | 2014 | 190 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2021 | 1881 | 0.030 |
Why?
|
| Primary Prevention | 1 | 2020 | 1207 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13627 | 0.030 |
Why?
|
| Workflow | 1 | 2017 | 852 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 2022 | 1868 | 0.030 |
Why?
|
| Incidence | 3 | 2010 | 21391 | 0.030 |
Why?
|
| Morocco | 1 | 2012 | 30 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2017 | 1376 | 0.030 |
Why?
|
| Afghanistan | 1 | 2012 | 79 | 0.030 |
Why?
|
| Asia, Central | 1 | 2011 | 13 | 0.030 |
Why?
|
| Piperazines | 1 | 2003 | 2525 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2021 | 2414 | 0.030 |
Why?
|
| Systems Biology | 1 | 2016 | 482 | 0.020 |
Why?
|
| Vitamins | 1 | 2020 | 1634 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 3725 | 0.020 |
Why?
|
| Software | 1 | 2006 | 4419 | 0.020 |
Why?
|
| Asia, Southeastern | 1 | 2011 | 113 | 0.020 |
Why?
|
| Markov Chains | 1 | 2015 | 968 | 0.020 |
Why?
|
| Health Surveys | 1 | 2002 | 4063 | 0.020 |
Why?
|
| Pregnancy | 3 | 2010 | 29746 | 0.020 |
Why?
|
| Genome | 1 | 2019 | 1739 | 0.020 |
Why?
|
| Organic Anion Transporters | 1 | 2012 | 100 | 0.020 |
Why?
|
| Lens, Crystalline | 1 | 2013 | 388 | 0.020 |
Why?
|
| Overweight | 1 | 2022 | 2421 | 0.020 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2010 | 1348 | 0.020 |
Why?
|
| Flucytosine | 1 | 2010 | 33 | 0.020 |
Why?
|
| Coffee | 1 | 2015 | 582 | 0.020 |
Why?
|
| Renin-Angiotensin System | 1 | 2016 | 738 | 0.020 |
Why?
|
| Internationality | 1 | 2016 | 1004 | 0.020 |
Why?
|
| Linguistics | 1 | 2011 | 106 | 0.020 |
Why?
|
| Infant, Newborn | 3 | 2021 | 26179 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2003 | 3016 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1996 | 3085 | 0.020 |
Why?
|
| Russia | 1 | 2011 | 381 | 0.020 |
Why?
|
| DNA | 1 | 2004 | 7233 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2002 | 3300 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2015 | 782 | 0.020 |
Why?
|
| Lipids | 1 | 2021 | 3336 | 0.020 |
Why?
|
| Protons | 1 | 2015 | 1114 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39262 | 0.020 |
Why?
|
| Corneal Transplantation | 1 | 2013 | 321 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2002 | 3149 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2017 | 2326 | 0.020 |
Why?
|
| Serotyping | 1 | 2010 | 324 | 0.020 |
Why?
|
| Data Mining | 1 | 2014 | 553 | 0.020 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2010 | 137 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2005 | 15286 | 0.020 |
Why?
|
| Homeostasis | 1 | 2020 | 3306 | 0.020 |
Why?
|
| Diuretics | 1 | 2012 | 613 | 0.020 |
Why?
|
| Obstetric Labor, Premature | 1 | 2010 | 274 | 0.020 |
Why?
|
| Insulin | 1 | 2002 | 6596 | 0.020 |
Why?
|
| Lentivirus | 1 | 2010 | 506 | 0.020 |
Why?
|
| Pain | 1 | 2003 | 5066 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2021 | 7593 | 0.020 |
Why?
|
| Genomics | 2 | 2015 | 5795 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2013 | 1602 | 0.020 |
Why?
|
| Acute Disease | 1 | 2018 | 7268 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2022 | 54306 | 0.020 |
Why?
|
| Virus Replication | 1 | 1995 | 2432 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 2014 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2003 | 9406 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 2013 | 1273 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 514 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2852 | 0.020 |
Why?
|
| Coronary Vessels | 1 | 2017 | 3112 | 0.020 |
Why?
|
| Time Factors | 3 | 2017 | 40139 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2013 | 1998 | 0.020 |
Why?
|
| Hematuria | 1 | 2006 | 233 | 0.020 |
Why?
|
| Neonatal Screening | 1 | 2010 | 595 | 0.020 |
Why?
|
| RNA | 1 | 1995 | 2723 | 0.020 |
Why?
|
| Siblings | 1 | 2009 | 824 | 0.020 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 3765 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2010 | 3602 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1996 | 13451 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2010 | 3607 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2021 | 11481 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10442 | 0.010 |
Why?
|
| Gene Regulatory Networks | 1 | 2012 | 1741 | 0.010 |
Why?
|
| Visual Acuity | 1 | 2013 | 2643 | 0.010 |
Why?
|
| Diabetic Retinopathy | 1 | 2013 | 1268 | 0.010 |
Why?
|
| HIV Seronegativity | 1 | 2004 | 208 | 0.010 |
Why?
|
| Gene Products, tax | 1 | 2003 | 51 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 21029 | 0.010 |
Why?
|
| Computational Biology | 1 | 2015 | 3505 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2015 | 3617 | 0.010 |
Why?
|
| Internet | 1 | 2015 | 3078 | 0.010 |
Why?
|
| Pandemics | 1 | 2022 | 8623 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 2004 | 388 | 0.010 |
Why?
|
| Blood Donors | 1 | 2004 | 343 | 0.010 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2003 | 184 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 11713 | 0.010 |
Why?
|
| Gestational Age | 1 | 2010 | 3564 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 3448 | 0.010 |
Why?
|
| Trisomy | 1 | 2003 | 260 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2017 | 18955 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2003 | 452 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2010 | 2092 | 0.010 |
Why?
|
| Karyotyping | 1 | 2003 | 1172 | 0.010 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2003 | 431 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2023 | 23374 | 0.010 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 548 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 2004 | 1166 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2013 | 3959 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2010 | 2907 | 0.010 |
Why?
|
| Mice | 2 | 2020 | 81209 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2003 | 1599 | 0.010 |
Why?
|
| Cell Line | 1 | 2012 | 15620 | 0.010 |
Why?
|
| DNA Primers | 1 | 2003 | 2818 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2010 | 3696 | 0.010 |
Why?
|
| Viral Load | 1 | 2007 | 3322 | 0.010 |
Why?
|
| Benzamides | 1 | 2003 | 1369 | 0.010 |
Why?
|
| Albuminuria | 1 | 2001 | 659 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 7805 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2004 | 2668 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2007 | 6498 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6238 | 0.010 |
Why?
|
| RNA, Satellite | 1 | 1995 | 17 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 6130 | 0.010 |
Why?
|
| Biopsy | 1 | 2006 | 6771 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 4899 | 0.010 |
Why?
|
| Kidney Failure, Chronic | 1 | 2006 | 2470 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 16932 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2004 | 2608 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2003 | 2418 | 0.010 |
Why?
|
| Virion | 1 | 1995 | 421 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 5797 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 14661 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1995 | 899 | 0.010 |
Why?
|
| Prognosis | 1 | 2006 | 29661 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2007 | 64981 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2006 | 36286 | 0.000 |
Why?
|